{"id":"W2109611268","doi":"10.1016/s1470-2045(15)00201-6","title":"Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":false,"ca_institutions":"Vancouver General Hospital","funders":"National Cancer Institute; Sunesis","keywords":"Cytarabine; Medicine; Refractory (planetary science); Placebo; Myeloid leukaemia; Double blind; Internal medicine; Chemotherapy; Physics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004155756,0.000645749,0.002802406,0.0005160921,0.0002556917,0.00005208016,0.0008715108,0.000422944,0.0002771982],"category_scores_gemma":[0.00235386,0.0003708538,0.0001695619,0.0009474264,0.0005068621,0.0002896503,0.0003363013,0.001841782,0.0002379932],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006851929,"about_ca_system_score_gemma":0.005553394,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005953126,"about_ca_topic_score_gemma":0.00282484,"domain_scores_codex":[0.9941397,0.00116304,0.001167971,0.0008993927,0.001420031,0.001209915],"domain_scores_gemma":[0.9931511,0.003619574,0.0006082805,0.00124796,0.0008614329,0.0005116573],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.970024,0.003705395,0.003697073,0.00005812451,0.001454376,0.001118746,0.003641857,0.0009575094,0.00007559603,0.00002964547,0.01442374,0.0008139358],"study_design_scores_gemma":[0.9522977,0.02383441,0.00289844,0.00008528773,0.0008223964,0.0000708324,0.00140909,0.004227944,0.00004610452,0.00001029911,0.01387434,0.0004231432],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9723762,0.0001900346,0.00009158526,0.007750268,0.0006179716,0.01532339,0.00006141999,0.000167128,0.003422032],"genre_scores_gemma":[0.989919,0.000173804,0.0009776512,0.0009229481,0.001001,0.003281814,0.0004323012,0.0001246809,0.003166778],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02012902,"threshold_uncertainty_score":0.9998744,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09009627044355988,"score_gpt":0.3851158234666294,"score_spread":0.2950195530230695,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}